Reuters -- Valeant Pharmaceuticals International said preliminary results showed its experimental drug for the treatment of pain associated with shingles failed to meet the main goal of a mid-stage trial.
Reuters -- Valeant Pharmaceuticals International said preliminary results showed its experimental drug for the treatment of pain associated with shingles failed to meet the main goal of a mid-stage trial.
